YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
12.25
+2.13 (21.05%)
At close: Nov 14, 2025, 4:00 PM EST
12.49
+0.24 (1.96%)
After-hours: Nov 14, 2025, 7:12 PM EST
Company Description
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
The company is based in Taipei, Taiwan.
Contact Details
Address: No. 3, Xingnan St., 12F. Taipei, 115001 Taiwan | |
| Website | ydesgroup.com |
Stock Details
| Ticker Symbol | YDES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002011674 |
| CUSIP Number | G98301107 |
| ISIN Number | KYG983011076 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| J. Ramsey | Chief Executive Officer |
| J. Ramsey | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 24, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 30, 2025 | 6-K | Report of foreign issuer |
| Sep 26, 2025 | 6-K | Report of foreign issuer |
| Sep 23, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Sep 19, 2025 | 6-K | Report of foreign issuer |
| Sep 5, 2025 | 20FR12B | Filing |
| Aug 28, 2025 | CERT | Certification by an exchange approving securities for listing |
| Aug 20, 2025 | 8-A12B | Registration of securities |
| Aug 15, 2025 | 6-K | Report of foreign issuer |
| Jul 18, 2025 | EFFECT | Notice of Effectiveness |